ConductScience.org, home

Gene · 56999

ADAMTS9: ADAM metallopeptidase with thrombospondin type 1 motif 9

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. ADAMTS9: ADAM metallopeptidase with thrombospondin type 1 motif 9. Genes, record 56999. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/56999

On this page

Gene

Symbol
ADAMTS9
HGNC
Name
ADAM metallopeptidase with thrombospondin type 1 motif 9
HGNC
NCBI Gene ID
56999
NCBI Gene
HGNC ID
HGNC:13202
HGNC
Ensembl
ENSG00000163638
NCBI Gene
Aliases
KIAA1312
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q9P2N4A disintegrin and metalloproteinase with thrombospondin motifs 91,9350Ensembl, GeneID, HGNC

Source UniProt

Patents31

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1436472Q9P2N4Espacenet
EP 4650780 A22025-11-1914245Q9P2N4Espacenet
EP 4641201 A22025-10-2916637Q9P2N4Espacenet
JP 2025147176 A2025-10-06369Q9P2N4Espacenet
JP 2025529142 A2025-09-045399Q9P2N4Espacenet
US 12371689 B22025-07-295399Q9P2N4Espacenet
JP 2025517969 A2025-06-1216637Q9P2N4Espacenet
JP 2025517970 A2025-06-1214245Q9P2N4Espacenet
JP 2025062604 A2025-04-142313Q9P2N4Espacenet
JP 2025032204 A2025-03-1124067Q9P2N4Espacenet

1 to 10 of 31

See all 31 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,303

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleADAMTS9 papersNewest fiscal year
P30DK063491Diabetes Research Center (DRC)122025
R01DK062370Identifying Genes for Type 2 Diabetes: FUSION92025
P30DK020572Michigan Diabetes Research Center (MDRC)82025
R01HL086694From GWAS loci to blood pressure genes, variants & mechanisms - Renewal82025
ZIAHG000024Genetic analysis of type II diabetes82025
P30CA068485Cancer Center Support Grant52025
P30ES010126UNC Center for Environmental Health and Susceptibility52025
P2CHD050924Carolina Population Center42025
R01DK075787Biological Insights from Genetic Investigation of ANthropometric Traits (GIANT) Across the Allelic Spectrum42025
R01DK093757Genetic epidemiology of rare and regulatory variants for metabolic traits42025

1 to 10 of 1,303Source NIH's project files

See all 1,303 nih grants

Papers1,498

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Conflicting Molecular Hallmarks of Lipedema Reflect Cell-Composition Confounding: A Reanalysis and Germline Reframing.Cureus202642824866PubTator, text miningPubMed
Combined vitamins D3 and K2 as potential modulators of multiple myeloma cell pathophysiology: transcriptomic and epigenetic effects under standard culture and bone marrow-like conditions.Front Oncol202642807170PubTator, text miningPubMed
Circulating Serum AGRN and ADAMTS8 With Related Candidates as Potential Biomarkers for Carotid Plaque Presence and Vulnerability.CNS Neurosci Ther202642747227PubTator, text miningPubMed
CAN the variants in the THADA and ADAMST9 genes be common risk factors for type 2 diabetes development and obesity.Mol Biol Rep202642319597PubTator, text miningPubMed
Genetic factors associated with response to as-needed brolucizumab treatment for exudative age-related macular degeneration.Jpn J Ophthalmol202642154379PubTator, text miningPubMed
ADAMTS9-AS2 acts as an epigenetic brake to constrain DNMT3B-mediated CADM2 silencing in esophageal squamous cell carcinoma metastasis.Front Immunol202641869309PubTator, text miningPubMed
Endothelial Cell Differentiation-Related CircRNAs Drive the Differentiation of Vascular Endothelial Cells.Biochem Genet202641779083PubTator, text miningPubMed
Soluble Notch agonist enables human ameloblast maturation and enamel-like tissue formation for tooth regeneration.Int J Oral Sci202641765949PubTator, text miningPubMed
Metabolic Mechanisms in Electroconvulsive Therapy for Schizophrenia: Role, Potential and Future Directions.Int J Mol Sci202641751887PubTator, text miningPubMed
Genome-wide analysis of gene and air pollution interactions on COPD in the CLSA cohort.Environ Res202641571064PubTator, text miningPubMed

1 to 10 of 1,498

See all 1,498 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/56999

GET https://conductscience.org/api/genes/v1/56999/patents?page=2